Clinical Trials Browser

Phase 1/2 × INDUSTRY × forodesine × Clear all

NCT00742495 2012-10-24

BCX1777-108

Phase 1/2 Terminated

LymphoidOther hematologic neoplasm

Recurrence, Lymphoma, T-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00289562 2012-01-20

Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma

NCT00035022 2006-01-13

Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphoid, Lymphoma